Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jul 11;295(6590):78-80.
doi: 10.1136/bmj.295.6590.78.

IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease)

IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease)

A Fornasieri et al. Br Med J (Clin Res Ed). .

Abstract

Circulating IgA-antigliadin antibodies were detected with enzyme linked immunosorbent assay (ELISA) in four of 121 patients (3%) who had IgA mesangial nephropathy and 14 of 17 children (82%) who had untreated coeliac disease. No positive cases were present in the 54 healthy subjects of the control group. Three patients who had IgA nephropathy and IgA-antigliadin antibodies underwent jejunal biopsy, and two showed mucosal atrophy. In these two patients urinary abnormalities, together with the IgA-antigliadin antibodies, disappeared completely after three months and five months, respectively, of following a gluten free diet. Circulating IgA immune complexes were found in most patients who had coeliac disease and Berger's disease associated with IgA-antigliadin antibodies, suggesting overactivity of the B cells producing IgA in both conditions. By contrast, a circulating IgA rheumatoid factor was detectable in three of the four patients who had IgA nephropathy and asymptomatic coeliac disease but was always absent in children who had coeliac disease but did not show signs of renal disease. These results suggest that a more complex abnormality in the IgA immune response is necessary for renal disease to become manifest in patients who have gluten enteropathy.

PubMed Disclaimer

References

    1. Lancet. 1972 Nov 18;2(7786):1065-7 - PubMed
    1. Lancet. 1986 Jul 26;2(8500):215 - PubMed
    1. J Immunol. 1980 Aug;125(2):763-70 - PubMed
    1. Kidney Int. 1980 Sep;18(3):366-74 - PubMed
    1. Clin Exp Immunol. 1982 Feb;47(2):309-16 - PubMed

Publication types

LinkOut - more resources